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Abstract 
Objective: The aim of this study was to evaluate the presence of human papillomavirus  (HPV) in saliva rinses of 
patients with oral squamous cell carcinoma (OSCC)and to analyze the  possibility of using saliva as a diagnostic 
method for screening high-risk patients.  Study design: The saliva sample of 22 patients with oral squamous cell 
carcinoma and 20  age-sex matched healthy controls were obtained. The presence of HPV 6, 11, 16, 18, 31,  and 33 
was evaluated by polymerase chain reaction (PCR).  Results: In 40.9% of the patients and in 25% of the controls, 
the saliva was shown to be  positive for HPV. In 27.3% of the patients and in 20% of the controls, the saliva was 
shown to be positive for HPV16; and none of the controls, except one patient was shown  to be positive for HPV 18. 
Neither patients nor controls were positive for HPV 31 and  33. These differences were not statistically significant. 
Conclusions: The results of this study were unable to support the detection of HPV in  saliva rinses as a diagnostic 
method for OSCC. 
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Introduction
Oral squamous cell carcinoma (OSCC) accounts for 
over 90 percent of oral cancers (1). Established etiologi-
cal factors of OSCC included cigarette smoking, heavy 
alcohol abuse, betel nut chewing, and smokeless tobacco 
use. However, a growing group of patients, including a 
large proportion of young adults and women, have no 
known tobacco or alcohol exposure. Increasingly re-
searches have focused on identifying possible viral etio-
logic factors such as oncogenic human papilloma virus 
(HPV) (2).
The absence of definite early warning signs for most 
head and neck cancers suggests that sensitive and spe-
cific biomarkers are likely to be important in screening 
high-risk patients (3). A number of molecular markers 
have been used to detect these tumors with varying de-
grees of specificity and sensitivity. No reliable or clini-
cally applicable marker has been shown to universally 
identify oropharyngeal squamous cell carcinoma or tu-
mor aggressiveness. Therefore, development of a saliva-
based screening test for oropharyngeal cancer may be 
able to detect early stage tumors before development of 
clinical symptoms (4).
Application of a real-time PCR technique in determina-
tion of HPV DNA level in head and neck tumor and pre-
malignant tissues as well as in serum has been evaluated. 
Recent studies investigated HPV DNA in saliva rinses 
from patients with OSCC, but there is a controversy 
(5). 
The aim of this study was to detect HPV in saliva of 
patients with OSCC by PCR in order to evaluate the pos-
sibility of using saliva rinse as a simple method of HPV 
detection in OSCC.
Material and Method
Patients and sample collection
Twenty two histopathologically confirmed OSCC pa-
tients participated in the study. The patients suspicious to 
OSCC were referred to Oral Medicine Department, Fac-
ulty of Dentistry, Tehran University of Medical Sciences 
and Meraj Institute. For each case, a healthy individual 
was selected from individuals visited oral medicine clin-
ic for routine dental care as control that was matched for 
age, sex, and in some extent smoking condition. History 
of any head and/or neck lesion was considered as an ex-
clusion criterion for the control participants. 
The trial was performed in accordance with the De-
claration of Helsinki and subsequent revisions (6) and 
approved by ethics committee at Tehran University of 
Medical Sciences. The details of the study were ex-
plained to all participants and written informed consents 
were obtained before entering into the study. 
Corresponding pretreatment saliva and control saliva 
were collected by 10ml normal saline rinses that was 
gargled and expectorated. Samples were centrifuged (10 
min, 3000 × g, 4C min) and supernant were discarded. 
Lysis buffer (10mM Trish-HCL, pH 8, 1mM MEDTA, 
1% SDS, 1M NaCl) and proteinase K were added on the 
cell pellets and were incubated in 56˚C for 2 hours. The 
standard phenol-chloroform extraction and the ethanol 
precipitation were used for DNA purification and the 
pelleted DNA was resuspended in 50-100 μ1/41 of tridis-
tilled sterile water (7). In order to determine the quality 
and quantity of the isolated DNA, each DNA was analy-
sed by electrophoresis on 0.8% agarose gels stained with 
ethidium bromide and spectrophotometrically.
Polymerase chain reaction (PCR)
DNA samples were amplified with the GP5+ and GP6+ 
primers targeting the L1 open reading frame of broad 
spectrum HPV genomes (7). In all samples, the cons-
titutively expressed SRY gene was amplified first to 
confirm the adequacy of the extracted DNA and PCR 
amplification. DNA from Caski and Hella cells was used 
as positive control in all preliminary PCR runs. Positive 
samples were further analyzed with type specific HPV 
primers to identify high risk (HPV 16 and 18), interme-
diate risk (HPV 31 and 33), and low risk (HPV 6 and 
11). The results of genotype were verified by restric-
tion fragment length polymorphism (RFLP) which used 
restriction enzymes BamHI, DdeI, HaeIII, HinfI, Pst I, 
RsaI and Sau 3AI (8). CaSki cell line (containing a high 
copy number of HPV 16) and HeLa cell line (containing 
HPV 18) were all received from Magdalena Grce.
Statistical analysis
Statistical analysis was performed using SPSS 11.5 soft-
ware. Chi-Square and Fisher exact were used for data 
analysis. P<0.05 was considered to be statistically sig-
nificant.
Results
Twenty two patients with oral squamous cell carcinoma 
and twenty healthy individuals were enrolled in this 
study. The case group included 13 females (59.09%) and 
9 males (40.01%) with mean age of 64.2 ± 14.9 years 
and the control group included 12 females (60%) and 8 
males (40%) with mean age of 64.4 ± 15. Five subjects 
from the case group (22.72%) and four subjects from 
the control group (20%) were smoker by the time of text 
and had history of smoking for at least 20 years. The 
involved sites in this study was tongue (n=10; 45.45%), 
alveolar ridge (n=4; 18.18%), floor of the mouth (n=3; 
13.6%), buccal mucosa (n=2; 9.09%), lips (n=2, 9.09%), 
and gingivae (n=1; 4.5%)
The saliva of nine patients (40.9%) and five controls 
(25%) were positive for HPV. The table 1 compares the 
presence of HPV types in saliva of oral squamous cell 
carcinoma patients and healthy individuals. Although the 
presence of all types of HPV in saliva of oral squamous 
cell carcinoma patients was higher than control group but 
none of these differences were statistically significant.
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Discussion
A link between human papillomavirus and squamous 
cell carcinoma of the head and neck was suggested more 
than 20 years ago (9). Investigators showed a strong as-
sociation between hig-risk-HPV infection and OSCC in 
Mexican, Sweden, Japanese, and Chinese populations 
(10-12). The role of high-risk oncogenic HPV in pre-
malignant and malignant oral lesions has been an issue 
of extreme controversy with conflicting data reported by 
numerous studies. Its prevalence reported in OSCC vary 
from <5% to 100% (13). This wide range may due to a 
variety of reasons such as the choice of primers used in 
the PCR, inherent differences in the populations being 
studied, and the methods used for HPV detection (14). 
PCR techniques are very sensitive and in the absence 
of a quantitative method such as Real-Time PCR, in-
significant virus (with no role in carcinogenesis) can be 
identified (9). In terms of sensitivity and specificity, in 
situ detection techniques of HPV in paraffin-embedded 
tissue sections of OSCC (using in situ PCR and in situ 
hybridization PCR) are more powerful in detecting HPV 
than the liquid-phase PCR methods (14). In contrast, 
Enzyme Linked Immune Assay (ELISA) lacks accept-
able sensitivity in detecting clinically meaningful HPV 
infections (9). 
In this study, the amount of genomic DNA obtained from 
saliva was about 2μg and sufficient for evaluation of 
HPV, in accordance with previous researches (15). HPV 
16 was the most detectable virus in patient’s salivary 
samples. This result was similar to other investigations 
that reported most prevalence and most carcinogenesis 
role for HPV 16 (2, 5, 16) but no relationship was found 
between HPV DNA test results from saliva rinses and 
OSCC. Herrero et al. (17), also, did not find a correlation 
between HPV presence in oral brush and head and neck 
tumor tissues. In contrast, in a study by Zhao et al. (5), 
it was shown that HPV 16 DNA in saliva rinses can re-
flect HPV 16 status of primary head and neck squamuos 
cell carcinoma. They found site specific preponderance 
of HPV 16 presence in oropharynx tumors as reported 
by other investigators (2,11,18). They suggest that quan-
titative analysis of HPV 16 in salivary rinses have 99% 
specificity but its significant expense and high rate of 
false-positive results make this test difficult to apply to 
a broad population. Smith et al. (19) demonstrated the 
statically significant association between the detection 
of HPV-high risk (HPV-HR) types in oral exfoliated 
cells and the presence of HPV-HR types in tumor tissue. 
They suggested that HPV testing of oral rinses may be 
predictive of an HPV-related head and neck cancer.
HPV 33 and 31 that were high risk for cervical cancers 
(20), were not found in saliva samples of neither squamous 
cell carcinoma patients nor healthy individuals.
In this study, saliva was collected by 10ml gargled and 
expectorated normal saline rinses that was similar to the 
study conducted by Zhao et al. (5) and Smith et al. (19). 
Furrer et al. (16) used superficial scrapes and demon-
strated that in potentially malignant and malignant oral 
lesions, HPV DNA is more likely to be detected in su-
perficial scraps than in biopsy specimens.
The results of this study, probably because of small sam-
ple size did not show that detection of HPV in saliva 
rinses could be used as a diagnostic method for OSCC. 
However, further studies are needed to approve or disap-
prove this method as a diagnostic one for OSCC.
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